Ludmila Bezerra da Silva
Instituto Butantan
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Ludmila Bezerra da Silva.
The Journal of Infectious Diseases | 2012
Mónica Marcela Castiblanco-Valencia; Tatiana R. Fraga; Ludmila Bezerra da Silva; Denize Monaris; Patrícia A.E. Abreu; Stefanie Strobel; Mihály Józsi; Lourdes Isaac; Angela S. Barbosa
Leptospira, the causative agent of leptospirosis, interacts with several host molecules, including extracellular matrix components, coagulation cascade proteins, and human complement regulators. Here we demonstrate that acquisition of factor H (FH) on the Leptospira surface is crucial for bacterial survival in the serum and that these spirochetes, besides interacting with FH, FH related-1, and C4b binding protein (C4BP), also acquire FH like-1 from human serum. We also demonstrate that binding to these complement regulators is mediated by leptospiral immunoglobulin-like (Lig) proteins, previously shown to interact with fibronectin, laminin, collagen, elastin, tropoelastin, and fibrinogen. Factor H binds to Lig proteins via short consensus repeat domains 5 and 20. Competition assays suggest that FH and C4BP have distinct binding sites on Lig proteins. Moreover, FH and C4BP bound to immobilized Ligs display cofactor activity, mediating C3b and C4b degradation by factor I. In conclusion, Lig proteins are multifunctional molecules, contributing to leptospiral adhesion and immune evasion.
Infection and Immunity | 2010
Angela S. Barbosa; Denize Monaris; Ludmila Bezerra da Silva; Zenaide Maria de Morais; Silvio Arruda Vasconcellos; Aurora M. Cianciarullo; Lourdes Isaac; Patrícia A.E. Abreu
ABSTRACT We have previously shown that pathogenic leptospiral strains are able to bind C4b binding protein (C4BP). Surface-bound C4BP retains its cofactor activity, indicating that acquisition of this complement regulator may contribute to leptospiral serum resistance. In the present study, the abilities of seven recombinant putative leptospiral outer membrane proteins to interact with C4BP were evaluated. The protein encoded by LIC11947 interacted with this human complement regulator in a dose-dependent manner. The cofactor activity of C4BP bound to immobilized recombinant LIC11947 (rLIC11947) was confirmed by detecting factor I-mediated cleavage of C4b. rLIC11947 was therefore named LcpA (for leptospiral complement regulator-acquiring protein A). LcpA was shown to be an outer membrane protein by using immunoelectron microscopy, cell surface proteolysis, and Triton X-114 fractionation. The gene coding for LcpA is conserved among pathogenic leptospiral strains. This is the first characterization of a Leptospira surface protein that binds to the human complement regulator C4BP in a manner that allows this important regulator to control complement system activation mediated either by the classical pathway or by the lectin pathway. This newly identified protein may play a role in immune evasion by Leptospira spp. and may therefore represent a target for the development of a human vaccine against leptospirosis.
Infection and Immunity | 2015
Ludmila Bezerra da Silva; Lidia dos Santos Miragaia; Leandro Carvalho Dantas Breda; Cecilia M. Abe; Mariana Costa Braga Schmidt; Ana Maria Moro; Denize Monaris; Jonas Nascimento Conde; Mihály Józsi; Lourdes Isaac; Patrícia A.E. Abreu; Angela S. Barbosa
ABSTRACT Upon infection, pathogenic Leptospira species bind several complement regulators in order to overcome host innate immunity. We previously characterized a 20-kDa leptospiral surface protein which interacts with C4b binding protein (C4BP): leptospiral complement regulator-acquiring protein A (LcpA). Here we show that LcpA also interacts with human factor H (FH), which remains functionally active once bound to the protein. Antibodies directed against short consensus repeat 20 (SCR20) inhibited binding of FH to LcpA by approximately 90%, thus confirming that this particular domain is involved in the interaction. We have also shown for the first time that leptospires bind human vitronectin and that the interaction is mediated by LcpA. Coincubation with heparin blocked LcpA-vitronectin interaction in a dose-dependent manner, strongly suggesting that binding may occur through the heparin binding domains of vitronectin. LcpA also bound to the terminal pathway component C9 and inhibited Zn2+-induced polymerization and membrane attack complex (MAC) formation. Competitive binding assays indicated that LcpA interacts with C4BP, FH, and vitronectin through distinct sites. Taken together, our findings indicate that LcpA may play a role in leptospiral immune evasion.
PLOS ONE | 2014
Natália Salazar; Mónica Marcela Castiblanco-Valencia; Ludmila Bezerra da Silva; Íris Arantes de Castro; Denize Monaris; Hana Paula Masuda; Angela S. Barbosa; Ana Paula Mattos Arêas
Infections caused by Staphylococcus aureus – particularly nosocomial infections - represent a great concern. Usually, the early stage of pathogenesis consists on asymptomatic nasopharynx colonization, which could result in dissemination to other mucosal niches or invasion of sterile sites, such as blood. This pathogenic route depends on scavenging of nutrients as well as binding to and disrupting extracellular matrix (ECM). Manganese transport protein C (MntC), a conserved manganese-binding protein, takes part in this infectious scenario as an ion-scavenging factor and surprisingly as an ECM and coagulation cascade binding protein, as revealed in this work. This study showed a marked ability of MntC to bind to several ECM and coagulation cascade components, including laminin, collagen type IV, cellular and plasma fibronectin, plasminogen and fibrinogen by ELISA. The MntC binding to plasminogen appears to be related to the presence of surface-exposed lysines, since previous incubation with an analogue of lysine residue, ε-aminocaproic acid, or increasing ionic strength affected the interaction between MntC and plasminogen. MntC-bound plasminogen was converted to active plasmin in the presence of urokinase plasminogen activator (uPA). The newly released plasmin, in turn, acted in the cleavage of the α and β chains of fibrinogen. In conclusion, we describe a novel function for MntC that may help staphylococcal mucosal colonization and establishment of invasive disease, through the interaction with ECM and coagulation cascade host proteins. These data suggest that this potential virulence factor could be an adequate candidate to compose an anti-staphylococcal human vaccine formulation.
PLOS Neglected Tropical Diseases | 2015
Leandro Carvalho Dantas Breda; Ching-Lin Hsieh; Mónica Marcela Castiblanco Valencia; Ludmila Bezerra da Silva; Angela S. Barbosa; Anna M. Blom; Chang Yung-Fu; Lourdes Isaac
The complement system consists of more than 40 proteins that participate in the inflammatory response and in pathogen killing. Complement inhibitors are necessary to avoid the excessive consumption and activation of this system on host cells. Leptospirosis is a worldwide zoonosis caused by spirochetes from the genus Leptospira. Pathogenic leptospires are able to escape from complement activation by binding to host complement inhibitors Factor H [FH] and C4b-binding protein (C4BP) while non-pathogenic leptospires are rapidly killed in the presence of fresh serum. In this study, we demonstrate that complement control protein domains (CCP) 7 and 8 of C4BP α-chain interact with the outer membrane proteins LcpA, LigA and LigB from the pathogenic leptospire L. interrogans. The interaction between C4BP and LcpA, LigA and LigB is sensitive to ionic strength and inhibited by heparin. We fine mapped the LigA and LigB domains involved in its binding to C4BP and heparin and found that both interactions are mediated through the bacterial immunoglobulin-like (Big) domains 7 and 8 (LigA7-8 and LigB7-8) of both LigA and LigB and also through LigB9-10. Therefore, C4BP and heparin may share the same binding sites on Lig proteins.
Research in Microbiology | 2017
Natália Salazar; Matilde Costa Lima de Souza; Amanda Gameiro Biasioli; Ludmila Bezerra da Silva; Angela S. Barbosa
A previous study had demonstrated that Leptospira enolase is secreted extracellularly by a yet unknown mechanism and reassociates with the bacterial membrane. Surface-anchored leptospiral enolase displays plasminogen binding activity. In this work, we explored the consequences of this interaction and also assessed whether Leptospira enolase might display additional moonlighting functions by interacting with other host effector proteins. We first demonstrated that enolase-bound plasminogen is converted to its active form, plasmin. The protease plasmin targets human fibrinogen and vitronectin, but not the complement proteins C3b and C5. Leptospira enolase also acts as an immune evasion protein by interacting with the negative complement regulators C4b binding protein and factor H. Once bound to enolase, both regulators remain functional as cofactors of factor I, mediating cleavage of C4b and C3b. In conclusion, enolase may facilitate leptospiral survival and dissemination, thus contributing to bacterial virulence. The identification and characterization of moonlighting proteins is a growing field of bacterial pathogenesis, as these multifaceted proteins may represent potential future therapeutic targets to fight bacterial infections.
Frontiers in Cellular and Infection Microbiology | 2018
Ludmila Bezerra da Silva; Milene C. Menezes; Eduardo S. Kitano; Ana K. Oliveira; Afonso G. Abreu; Gisele Oliveira de Souza; Marcos Bryan Heinemann; Lourdes Isaac; Tatiana R. Fraga; Solange M.T. Serrano; Angela S. Barbosa
Leptospires are highly motile spirochetes equipped with strategies for efficient invasion and dissemination within the host. Our group previously demonstrated that pathogenic leptospires secrete proteases capable of cleaving and inactivating key molecules of the complement system, allowing these bacteria to circumvent hosts innate immune defense mechanisms. Given the successful dissemination of leptospires during infection, we wondered if such proteases would target a broader range of host molecules. In the present study, the proteolytic activity of secreted leptospiral proteases against a panel of extracellular matrix (ECM) and plasma proteins was assessed. The culture supernatant of the virulent L. interrogans serovar Kennewicki strain Fromm (LPF) degraded human fibrinogen, plasma fibronectin, gelatin, and the proteoglycans decorin, biglycan, and lumican. Interestingly, human plasminogen was not cleaved by proteases present in the supernatants. Proteolytic activity was inhibited by 1,10-phenanthroline, suggesting the participation of metalloproteases. Moreover, production of proteases might be an important virulence determinant since culture-attenuated or saprophytic Leptospira did not display proteolytic activity against ECM or plasma components. Exoproteomic analysis allowed the identification of three metalloproteases that could be involved in the degradation of host components. The ability to cleave conjunctive tissue molecules and coagulation cascade proteins may certainly contribute to invasion and tissue destruction observed upon infection with Leptospira.
Biotechnology Reports | 2018
Rosa M. Chura-Chambi; Tatiana R. Fraga; Ludmila Bezerra da Silva; Bruno Bernardi Yamamoto; Lourdes Isaac; Angela S. Barbosa; Ligia Morganti
Highlights • HHP at alkaline pH induces non-denaturing solubilization of thermolysin IB.• Thermolysin is refolded at high yield by dialysis to pH 8.0.• SEC-purified thermolysin suffers autoproteolysis and became enzymatically active.• Recombinant thermolysin cleaves C3 in a dose- and time-dependent fashion.
Immunobiology | 2012
Mónica Marcela Castiblanco Valencia; Tatiana R. Fraga; Ludmila Bezerra da Silva; Denize Monaris; Patrícia A.E. Abreu; Angela S. Barbosa; Lourdes Isaac
Molecular Immunology | 2011
Mónica Marcela Castiblanco-Valencia; Tatiana R. Fraga; Ludmila Bezerra da Silva; D. Monaris; Patrícia A.E. Abreu; Stefanie Strobel; Mihály Józsi; Lourdes Isaac; Angela S. Barbosa